Trials / Conditions / HR+/HER2- Early Breast Cancer
HR+/HER2- Early Breast Cancer
4 registered clinical trials studyying HR+/HER2- Early Breast Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE NCT07521202 | Institut fuer Frauengesundheit | N/A |
| Recruiting | Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer NCT07531693 | Institut fuer Frauengesundheit | — |
| Recruiting | RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Ear NCT06797531 | Novartis Pharmaceuticals | — |
| Completed | A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER NCT07162051 | Xijing Hospital | Phase 2 |